Enrolment into phase III study of telaprevir begins.

By  

Inpharma, Vol. 1, Iss. 1661, 2008-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Gemcitabine and mitoxantrone in metastatic breast cancer: A phase-I-study

By Schmid Peter   Flath Bernd   Akrivakis Konstantin   Heilmann Volker   Mergenthaler Hans-Günther   Sezer Orhan   Kreienberg Rolf   Possinger Kurt  

Investigational New Drugs, Vol. 23, Iss. 4, 2005-08 ,pp. : 349-356

Springer Publishing Company

Access to resources Recommend Favorite

A Phase II Study of 9-Nitro-Camptothecin in Patients with Previously Treated Metastatic Breast Cancer

By Miller Kathy D.   Soule Sharon E.   Haney LaTrice G.   Guiney Patricia   Murry Darryl J.   Lenaz Luigi   Sun Show-Li   Sledge Jr George W.  

Investigational New Drugs, Vol. 22, Iss. 1, 2004-01 ,pp. : 69-73

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of gemcitabine in combination with vinorelbine versus gemcitabine followed by vinorelbine for metastatic breast cancer

By Park In   Ro Jungsil   Lee Keun   Kim Shi   Yun Young   Nam Byung  

Investigational New Drugs, Vol. 28, Iss. 5, 2010-10 ,pp. : 659-669

Springer Publishing Company

Access to resources Recommend Favorite

Phase II and Pharmacological Study of Oral Docetaxel Plus Cyclosporin A in Anthracycline Pre-Treated Metastatic Breast Cancer

By  

Current Clinical Pharmacology, Vol. 9, Iss. 2, 2014-05 ,pp. : 139-147

Bentham Science Publishers

Access to resources Recommend Favorite